Neuralstem to Present Clinical Update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day

GERMANTOWN, Md., Apr. 11 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, Chief Scientific Officer of Neuralstem, will be providing a clinical update at the Alliance for Regenerative Medicine 6th Annual Cell & Gene Therapy Investor Day at the Metropolitan Club in [...]